Therapeutic strategies using drugs which cause Lysosomal Cell Death have been proposed for eradication of resistant cancer cells. In this context, nanotherapy based on Magnetic Intra-Lysosomal Hyperthermia (MILH) generated by magnetic nanoparticles (MNPs) that are grafted with ligands of receptors overexpressed in tumors appears to be a very promising therapeutic option. However, mechanisms whereby MILH induces cell death are still elusive. Herein, using Gastrin-grafted MNPs specifically delivered to lysosomes of tumor cells from different cancers, we provide evidences that MILH causes cell death through a non-apoptotic signaling pathway. The mechanism of cell death involves a local temperature elevation at the nanoparticle periphery which enhances the production of reactive oxygen species through the lysosomal Fenton reaction. Subsequently, MILH induces lipid peroxidation, lysosomal membrane permeabilization and leakage of lysosomal enzymes into the cytosol, including Cathepsin-B which activates Caspase-1 but not apoptotic Caspase-3. These data highlight the clear potential of MILH for the eradication of tumors overexpressing receptors.
Introduction
Cancer is a leading cause of death with millions of new people diagnosed with cancer every year. One major reason that limits outcome and drug response of anti-cancer therapies is multidrug resistance [1] . However, recent studies have shown that cancer cells resistant to traditional therapies can be sensitive to agents which induce lysosomal cell death through lysosome membrane permeabilization (LMP) [2] . In fact, LMP can be triggered by a wide variety of stimuli including death ligands, oxidative stress and treatment by lysosomotropic agents [3] . In some circumstances (i.e. treatment by lysosomotropic agents), LMP appears to be an early event triggering apoptosis whereas in others (i.e. treatment by death ligands), LMP results from the activation of apoptosis signaling pathways and contributes to the amplification of death signals.
Alternatively to these above agents, we [4] and others [5, 6] have recently proposed that Magnetic Intra-Lysosomal Hyperthermia (termed MILH), induced by application of a high frequency alternating magnetic field (AMF) to cells containing magnetic nanoparticles (MNPs) in their lysosomes, is an effective way to specifically trigger lysosomal cell death in cancer cells [7] . This is the result of the heat released by MNPs when exposed to AMF. Moreover, MNPs offer the potential to be driven into lysosomes of tumor cells by grafting them with ligands or antibodies that recognize receptors overexpressed in tumors. Subsequently to their activation, receptors are internalized together with ligand-grafted MNPs and traffic to lysosomes [4, 5] . Using this strategy, we showed that minute amounts of iron oxide MNPs targeting gastrin receptors (CCK2R), overexpressed in most endocrine tumors, caused the death of cancer cells upon AMF exposure, making this approach an attractive therapeutic option [4, 8] . Strikingly, in this study, as in others, no perceptible temperature rise in the cell medium occurred during AMF exposure [4] [5] [6] . Thus, MILH differs from standard magnetic hyperthermia whereby tumor eradication is achieved with large doses of MNPs which cause a temperature elevation of the whole tumor [9] . However, it cannot be excluded that MILH also contributes to cell death during standard magnetic hyperthermia experiments since small amounts of MNP injected intra-tumourously could be internalized by cancer cells. In MILH, it is expected that MNPs, even of low heating power (Specific Absorption Rate), generate a local temperature rise causing LMP [4] [5] [6] 10] . However, this appealing hypothesis has never https://doi.org/10.1016/j.jconrel.2017.11.050 Received 6 September 2017; Received in revised form 28 November 2017; Accepted 30 November 2017 been directly proven experimentally. Moreover, the precise mechanisms leading to cell death by MILH remains largely unknown. Insight into these mechanisms is essential to optimize this approach in a therapeutic perspective.
To date, molecular mechanisms of lysosomal cell death of epithelial cells were mainly elucidated using lysosomotropic agents or death ligands which do not exclusively target lysosomes of cancer cells [11] [12] [13] . Lysosomal cell death through apoptosis was demonstrated to involve the release of lysosomal hydrolases into the cytosol, especially Cathepsin-D and Cathepsin-B (CathB) which digest apoptosis-regulated proteins, leading to mitochondrial outer membrane permeabilization (MOMP) and apoptotic caspases activation [3, 14] .
The aim of this study was to elucidate the cellular and molecular mechanisms involved in cancer cell death induced by MILH. Here, we report that, under an AMF, lysosome-accumulated MNPs increase the temperature very locally and enhance reactive oxygen species (ROS) production through the Fenton reaction within lysosomes. This causes lipid peroxidation of lysosome membrane, LMP and subsequent cell death by a non-conventional mechanism which is dependent on Caspase-1 and CathB but independent of apoptotic Caspase-3. These major advances in the understanding of the cell death mechanism occurring during MILH will facilitate optimization of the strategy in a therapeutic perspective.
Material and methods

Nanoparticles functionalization
The synthesis method and characterization of the magnetic nanoplatform used in the present article have been previously described [4] . The nanoplatform (Gastrin-MNP) is composed of commercial iron oxide magnetic nanoparticles (MNPs) coated with PEG-Amine (Gecco Dots, Sweden) and decorated with 100 molecules of a synthetic replicate of gastrin (Covalab) and 20 molecules of the fluorescent label NHS-DY647-PEG1 (Dyomics GmbH, Jena, Germany). The size of the magnetic core determined by transmission electron microscopy was 8.7 ± 1.6 nm. The specific absorption rate of these MNPs is 13 W/g Fe at 275 kHz and 40 mT. N-acetyl-cystein (NAC), Desferroxamine (DFO), Bafilomycine A (BafA1), Artesunate (ART) and FeCl 3 were purchased from Sigma-Aldrich. CA-074-Me and Caspase-3 inhibitors were from ApexBio. Caspase-1 inhibitor was from Santa Cruz Biotechnologies.
Cell lines
The glucagon-producing Hamster tumoral cell line INR1G9 stably expressing CCK2R (INR1G9-CCK2R) obtained as previously described [15] and the Thp1 human macrophage/monocyte cell line were cultured in RPMI1640 medium containing 10% fetal bovine serum (FBS) and 100 IU/ml penicillin/streptomycin (Life technologies). The HEK293 cells (Flp-In system, Invitrogen) stably expressing the CCK2R, named HEK-CCK2R, and the clone B13 of AR4-2J cells (kindly provided by Pr Timo Otonkoski, University of Helsinki, Finland, with the permission of Dr. Itaru Kojima, Gunma University, Maebashi, Japan) were cultured in DMEM medium containing 10% fetal bovine serum (FBS) and 100 IU/ml penicillin/streptomycin (Life technologies). The AGS gastric adenocarcinoma cell line was permanently transfected with CCK2R (AGS-CCK2R) driven by the EF1-α promoter under puromycin selection and grown in DMEM/F-12 medium supplemented with 10% FBS and 100 IU/ml penicillin/streptomycin [16] . The cells were grown in a humidified atmosphere at 95% air and 5% CO 2 at 37°C.
Cell treatment by alternating magnetic field
Cell treatment by alternating magnetic field (AMF) was performed as follows. Cells were seeded into 4-compartment Cellview dishes (Greiner Bio-One) at a density of 25 to 50 × 10 3 cells/cm 2 , grown overnight and incubated with Gastrin-MNPs (16 μg Fe/ml) for 24 h at 37°C in medium buffered with 10 mM HEPES buffer pH 7.4 containing 0.5% FBS and 100 IU/ml penicillin-streptomycin to allow Gastrin-MNPs internalization and accumulation in lysosomes. Incubation medium was withdrawn and cells were rinsed twice with incubation medium and then incubated with 5 mM NAC, 1 mM DFO, 1 nM BafA1, 20 μM ART, 10 μM CA-074-Me, 2.5 μM Caspase-1 inhibitor or 10 μM Caspase-3 inhibitor for 1 h or 120 μM FeCl 3 for 4 h and exposed to AMF (275 kHz, 40 mT) for 2 h using a commercial magnetic inductor (Fives Celes, Lautenbach, France) as previously described [4] . The temperature of the Cellview dish was maintained at 37.0 ± 0.2°C and controlled using a thermal probe (Reflex, Neoptix, Canada) placed in the incubation medium of the cells. At the end of the experiments, cells were placed in a humidified atmosphere at 5% CO 2 and 37°C. Different biological effects were analyzed following AMF exposure and summarized in Supplementary Table 1 .
Determination of cell death
The effects of AMF treatment were investigated as follows: first, cell survival was determined 24 h post-AMF treatment using a MTT viability assay. Secondly, dead cells labeled with AnnexinV-iFluor488 and propidium iodide (excitation: 488 and 540 nm respectively, AAT Bioquest) were counted 4 h after the end of AMF exposure as described before [4] . Gastrin-MNPs (16 μg Fe/ml) for 24 h at 37°C in medium buffered with 10 mM HEPES buffer pH 7.4 containing 0.5% FBS and 100 IU/ml penicillin-streptomycin. Cells were rinsed twice with incubation medium, exposed to AMF for 2 h, labeled with AnnexinV-iFluor555 (excitation: 540 nm, AAT Bioquest) 4 h after the end of AMF exposure and counted. Counting of labeled cells was carried out by analyzing confocal microscopy images (LSM510 confocal microscope, Zeiss) representing populations of 2000-3000 cells/experiment using ImageJ software.
Analysis of ROS production
INR1G9-CCK2R cells were seeded 24 h before the experiments onto 4-compartment Cellview dishes (Greiner Bio-One) at a density of 25 to 50× 10 3 cells/cm 2 and incubated with Gastrin-MNPs (16 μg Fe/ml) for 24 h. Cells were rinsed twice with incubation medium and incubated with 5 mM NAC, 1 mM DFO, 1 nM BafA1, 20 μM ART for 1 h or 120 μM FeCl3 for 4 h. For total ROS production analysis, cells were exposed to AMF for 2 h, rinsed with incubation medium, incubated with CellROX Green reagent (Molecular probes, Excitation wavelegnth: 488 nm), immediately after AMF exposure, in incubation medium according to manufacturer's instructions and quantification of ROS production was performed by analyzing the intensity of CellROX Green reagent labeling of confocal microscopy images (LSM780 confocal microscope, Zeiss) using Image J software. 2000-3000 cells/experiments were analyzed in at least 4 independent experiments. For initial ROS production analysis, cells having or not internalized Gastrin-MNPs were incubated in the presence or absence of 1 mM DFO, 1 nM BafA1, 20 μM ART or 120 μM FeCl3 and then with CellROX Green reagent (Molecular probes, Excitation: 488 nm) in incubation medium according to manufacturer's instructions, exposed to AMF for 30-min, rinsed with incubation medium and ROS production was analyzed using confocal microscopy (LSM780 confocal microscope, Zeiss) immediately after AMF exposure. Initial ROS production was quantified by fluorescence intensity ratio of For these experiments, the AMF was produced by a miniaturized home-made electromagnet placed in a CELLView dish and covered with RPMI containing 0.5% FBS, as previously described [17] . This permits to follow in real-time the evolution of the fluorescence of the MNPs under the application of AMF and thus to have an access to the local temperature. For these experiments, different positions were marked inside and outside the gap. Cells were exposed to the AMF (53 mT, 300 kHz). Before and during AMF application, fluorescence intensities of DY549 (excitation: 540 nm) and YFP-Lamp1 (excitation: 510 nm) were measured from confocal microscopy images LSM780 confocal microscope, Zeiss) using ImageJ software. 20-30 cells/experiment were analyzed from 4 independent experiments. [17] . Different positions were marked inside and outside the gap. Cells were exposed to the AMF (53 mT, 300 kHz) for 60-min. Before and during AMF application, CathB leakage from lysosome was analyzed by measuring the colocalization between the GFPCathB and RFP-Lamp1 proteins labeling from confocal microscopy images of the marked positions by measuring the % of green pixels (GFP-CathB) colocalized with red pixels (RFP-Lamp1) (ImageJ software). 20-30 cells/experiment were analyzed from 4 independent experiments. 
Statistical analysis
Results are expressed as the mean ± SEM of at least three independent experiments. Statistical analysis was performed using ANOVA test. Differences were considered significant when p < 0.05. 
Results
Magnetic Intra-Lysosomal Hyperthermia (MILH) enhances ROS production through the Fenton reaction within lysosomes
Over-expression of hormone receptors is a hallmark of neuroendocrine tumors which thus represent a perfect model for the experimentation of tumor cell targeting with ligand-grafted MNPs. We previously showed that Gastrin-grafted iron oxide MNPs (termed Gastrin-MNP) are internalized specifically by the pancreatic endocrine tumoral cells INR1G9 overexpressing the CCK2R (INR1G9-CCK2R cells) through a CCK2R-dependent physiological process, and are then trafficked to lysosomes where they accumulated (Fig. 1a) . Of note, Gastrin-MNPs exist under nano-objects containing nanoparticles and serum adsorbed proteins whose distribution slightly increased from a size around 37 to 50 nm after 24 h of incubation in cell culture medium (data not shown). Upon AMF exposure, Gastrin-MNPs killed 32.3 ± 2.7% of INR1G9-CCK2R cells by a phenomenon that we termed "Magnetic Intra-Lysosomal Hyperthermia" (MILH) [4] (Fig. 1a) . 4 h after MILH treatment, the rate of cell damage reached 19.9 ± 1.5% (i.e. 3.5 ± 0.3-fold basal) as indicated by AnnexinV and propidium iodide (AnnV/PI) labelings (Fig. 1a) . Both AnnV and PI labelings, which constitute early features of MILH cell death, were thus used throughout our study to appreciate cell death.
So far, our current knowledge on the mechanism of cancer cell death caused by MILH treatment is still elusive, although we and others identified cellular ROS production and lysosome leakage as biological events accompanying cell death [4, 5, 17] . To gain insight into cell death mechanisms, we hypothesized that AMF application to cells containing MNPs would generate a local temperature elevation and, inasmuch as MNPs are concentrated into lysosomes, heating of lysosome content would trigger a death signaling cascade initiated by the enhancement of ROS production within lysosomes. Indeed, in addition to being a major digestive compartment, lysosomes are well-known major sites of ROS production through the Fenton reaction (Fe 2+ + H 2 O 2 → Fe 3+ + OH -+ OH % ) which catalyzes the transformation of hydrogen peroxide to hydroxyl radicals. This reaction is dependent on low-molecular-weight iron derived from degraded iron-containing proteins, lysosomal lumen acidity and temperature [18] [19] [20] . It is also known that high levels of ROS cause lysosome membrane permeabilization (LMP) whereby lysosomal cathepsins, as well as other hydrolytic enzymes, are released from the lysosomal lumen to the cytosol and trigger cell death (Fig. 1a-b ) [21] . In INR1G9-CCK2R cells, MILH increased ROS levels by 5.7 ± 1.5-fold over the basal value (Fig. 1b, S1a ). Such effect is potentiated by the addition of FeCl 3 which increased ROS levels to 7.5 ± 0.7-fold. In contrast, intralysosomal chelation of iron by Desferrioxamine (DFO) [22] prevented MILH-increased cellular ROS production which returned nearly to the basal value (2.0 ± 0.5-fold over basal). Also, the inhibition of the vacuolar H + -ATPase pump by Bafilomicyne A (BafA1) treatment which caused intralysosomal pH rise (Fig. S1b) decreased MILH-induced cellular ROS level to 2.7 ± 0.4-fold over basal value (Fig. 1b, S1a) . Conversely, treatment of cells by Artesunate (ART), an activator of vacuolar H + -ATPase pump decreasing intralysosomal pH (Fig.S1b) [20] , increased MILH-enhanced cellular ROS production from 5.7 ± 1.5-to 8.3 ± 0.3-fold over basal value (Fig. 1b, S1a) .
We previously showed that ROS production was significantly detectable after 30-min of AMF exposure [17] . To precisely identify subcellular site(s) of ROS which are initially produced in MILH condition, a series of experiments combining confocal microscopy imaging and pharmacological agents were carried out. Firstly, analysis of confocal microscopy images indicated that fluorescent ROS sensor co-localized with Gastrin-MNPs in lysosomes after 30-min of AMF exposure (Fig. 1c) . Quantification of lysosomal ROS images showed that MILH enhanced ROS level by 2.0 ± 0.2-fold in the vicinity of Gastrin-MNPs within lysosomes (% of relative fluorescence Gastrin-MNP/ROS: 48.5 ± 3.9% vs 24.8 ± 1.1%). Moreover, addition of FeCl 3 augmented MILH-induced lysosomal ROS production by 1.3 ± 0.1-fold (% of relative fluorescence Gastrin-MNP/ROS: 60.7 ± 6.1% vs 48.5 ± 3.9%), wheareas DFO inhibited it (37.8 ± 5.8%). Variation of lysosomal pH also modified lysosmal ROS production. Indeed, while ART treatment increased MILH-induced lysosomal ROS production by 1.7 ± 0.1-fold (% of relative fluorescence Gastrin-MNP/ROS: 80.9 ± 8.5% vs 48.5 ± 3.9%), BafA1 inhibited it (24.7 ± 4.2%).
Together, these results demonstrate that MILH initially generates ROS through the Fenton reaction within lysosomes where Gastrin-MNPs are accumulated.
However, as the ROS production can occur in other subcellular sites, we also determined whether MILH also generates ROS by activating, for instance, the mitochondrial respiratory chain complex or NADPH oxidases which are transmembrane proteins mostly present at the plasma membrane, in endosomes and in endoplasmic reticulum [23] . We found that rotenone, an inhibitor of the mitochondrial respiratory chain complex, did not modify cellular ROS generation by MILH, whereas diphenyleneiodonium (DPI), an inhibitor of NADPH oxidases, decreased it (5.9 ± 1.8-and 3.8 ± 1.3-fold over basal value in the presence of rotenone or DPI, respectively versus 5.7 ± 1.5-fold) (Fig.  S2) . Hence, MILH initially triggers ROS production through the Fenton reaction within lysosomes and, likely secondary, through NADPH oxidases. Of note, no significant variation in ROS level was observed between the different conditions in the absence of AMF exposure (Fig.  S1a, S2) .
We further investigated the mechanism whereby MILH enhanced the Fenton reaction in lysosomes. Firstly, we examined the possibility that Fe ions, participating in the Fenton reaction, could originate from MNPs dissolution in lysosomes during AMF exposure. Indeed, it has been reported that iron oxide MNPs, in the absence of AMF application, are degraded through a lysosomal acidic and enzymatic lysis in the endo-lysosome compartment [24, 25] . On the other hand, another study performed at neutral pH, attributed ROS production to the catalytic reaction at the surface of MNPs rather than to being caused by dissolved iron from MNPs [26] . Using particle electron paramagnetic resonance (pEPR) to determine the quantity of iron contained in the cells under the form of MNPs, we found that internalized Gastrin-MNPs were not degraded following AMF application (0.94 ± 0.06 vs 0.92 ± 0.03 pg magnetic Fe/cell) (Fig. 1d) . However, we cannot exclude that iron could have been released from Gastrin-MNPs during their 24 h-trafficking in the endo-lysosome compartment prior to magnetic field application. Consequently, these results indicate that MILH-induced ROS production was the result of enhanced Fenton reaction catalysis using cellular lysosomal iron or possibly iron from MNPs, dissolved most likely before AMF application.
Secondly, we evaluated the temperature rise during MILH experiments. So far, our experimental data indicate that the death of cancer cells in MILH occurs without any perceptible rise in the global temperature of the medium. The hypothesis that local heating occurs at proximity of MNPs has been supported by several experimental reports [27] , but direct data accounting for such a phenomenon in MILH were still lacking. In particular, no intracellular or intra-lysosomal temperature measurement under magnetic hyperthermia experiments has been reported so far in the literature. We therefore conducted such experiments, using fluorescent molecular thermometers and the previously described miniaturized high-frequency electromagnet which enables confocal fluorescence imaging of cells during MILH experiments [17] . Molecular thermometers were composed of the fluorescent moieties DY549 attached to MNPs via PolyEthyleneGlycol of 7 nm- [4] . Intensity of fluorescence emission of the two probes was previously shown to depend on temperature [28] . This relationship was confirmed by the calibration curve showing linearity of fluorescence intensity decrease as a function of temperature increase (Fig. S3 ). Quantitative fluorescence imaging was then carried out on cells exposed to AMF for a limited duration (˂10-min) and incubated with ROS scavenger NAC in order to preserve lysosome integrity and avoid possible chemical quenching of the fluorescent molecular thermometers by ROS. As shown on Fig. 1e , fluorescence intensity of DY549 grafted to MNPs declined with the time of AMF exposure. According to the calibration curve (Fig. S3) , the percentage of decrease of fluorescence intensity observed after~7-min of treatment corresponds to a temperature increase of 14.1 ± 1.4°C, indicating that the temperature actually reached 51°C at 7 nm-distance from the MNP core. However, fluorescence intensity of YFP-Lamp1 did not significantly change during MILH experiments (Fig. 1e) . These results strongly support that AMF exposure to MNPs that have been accumulated in lysosomes causes a significant temperature increase at the immediate vicinity of the MNPs since it is not detected at the outer surface of lysosomes.
MILH-enhanced ROS production within lysosomes causes lysosomal membrane permeabilization and cell death
We further assessed the relationship between ROS generation within lysosomes and cell damage. ROS can destabilize and permeabilize lysosome membranes through lipid and protein peroxidation [3] . We performed experiments combining confocal microscopy imaging and pharmacological agents to analyze whether MILH induces the peroxidation of lysosomal lipids (Fig. 2a) . Analysis of confocal microscopy images indicated that MILH enhanced the level of lipid peroxidation which was detectable from 30-min of AMF application, and co-localized with Gastrin-MNPs (% of relative fluorescence: 74.4 ± 2.7% vs 41.5 ± 5.6%). Moreover, intralysosomal chelation of iron by DFO or BafA1 treatment decreased MILH-induced lysosomal lipid peroxidation (54.4 ± 3.1% and 48.7 ± 15.1%). Together, these results demonstrate that MILH induces lysosomal lipid peroxidation concomitantly with lysosomal ROS production.
Since MILH stimulates lysosomal ROS production and lipid peroxydation, it appeared likely that LMP subsequently occurs. Previously, we documented that, in MILH experiments, lysosomal integrity was affected as suggested by the decrease of lysosome labeling by LysoTracker. However, the criterium of LysoTracker labeling is insufficient to characterize LMP since it may account for leaking of low molecular weight components and not lysosomal enzymes which are key actors in lysosome functions. Herein, we determined whether ROS production in lysosomes truly triggered LMP. The decrease of CathB content in lysosomes (labeled with RFP-Lamp1) was chosen to represent lysosomal enzyme leakage (Fig. 2b) . In absence of AMF application, INR1G9-CCK2R cells having internalized Gastrin-MNPs presented a high level of GFP-CathB/RFP-Lamp1 colocalization which was reduced by the application of AMF (Pearson coefficient: 0.54 ± 0.03 vs 0.69 ± 0.02 in presence vs absence of AMF). The effect of MILH on GFP-CathB/RFP-Lamp1 colocalization was cancelled in the presence of the NAC scavenger (Pearson coefficient: 0.74 ± 0.03, Fig. 2b, S4) . Moreover, quantification of fluorescence intensity showed that MILH decreased lysosomal CathB levels by 19.2 ± 3.7% (% of relative fluorescence: 30.7 ± 3.9% vs 50.5 ± 3.8%), whereas addition of NAC prevented it (50.3 ± 5.8%). These results demonstrate that lysosomal leakage was entirely related to MILH-enhanced ROS production.
We then determined whether the leakage of CathB from lysosomes constituted an early event in the signaling cascade leading to cell death. During MILH experiments performed using the miniaturized electromagnet [17] , we evaluated in real-time the decrease of the colocalization of GFP-CathB with RFP-Lamp1, a protein resident of lysosome membrane (Fig. 2c) . Before or after AMF exposure, INR1G9-CCK2R cells having internalized Gastrin-MNPs presented a high level of GFPCathB/RFP-Lamp1 colocalization (Pearson coefficient > 0.70). However, the lysosomal CathB level decreased significantly by 25.4 ± 4.7% and 43.9 ± 6.3% after 30 and 60-min of MILH treatment respectively, demonstrating that leakage of lysosome content is an early event occurring concomitantly with the generation of lysosomal ROS. Of note, RFP-Lamp1 and GFP-CathB fluorescence intensities, other LMP markers [29] , decreased respectively by 20 ± 2.4% and 16.5 ± 6.6% from 30-min of AMF exposure (Fig. S7) , strongly suggesting that the changes in RFP-Lamp1 and GFP-CathB fluorescence represent respectively lysosomal rupture and CathB leakage from lysosome into the cytosol and that both events occur early in the signaling cascade leading to cell death.
Finally, we wished to establish the relationship between ROS generation within lysosomes and cell death MILH experiments. We found that the addition of FeCl 3 or ART, which enhance ROS production in the cell medium, augmented cell death induced by MILH (4.0 ± 0.3-and 4.1 ± 0.4-fold over basal value respectively vs 2.6 ± 0.2-fold in presence of Gastrin-MNP alone, Fig. 2d, S5 ). In contrast, NAC, DFO and BafA1 treatments which trapped ROS or inhibited their formation, prevented MILH-induced cell death (0.8 ± 0.1, 1.4 ± 0.1 and (Fig. 2d, S4-S5) . Moreover, MILH-induced cell death was not inhibited by rotenone or DPI (Fig. S6) , indicating that neither the mitochondria respiratory chain complex nor NADPH oxidases were involved in cell death, further supporting the idea that ROS generated by NADPH oxidases are secondary to lysosomal stress caused by MILH treatment. All together, these results demonstrate that lysosomal ROS production, which is enhanced by MILH through the Fenton reaction, is at the origin of cancer cell death.
Cancer cell death induced by MILH is dependent on CathB activity
In a previous study, we showed that MILH-induced cell death depends on lysosomal cysteine cathepsins which include cathepsins B, C, H, K, L, S and X [4] . Herein, we performed experiments to more precisely identify the enzyme(s) involved. A likely candidate is CathB which is involved in lysosomal cell death, abundant in lysosomes, overexpressed in cancers and maintains its activity at neutral pH [30] [31] [32] . MILH experiments were performed in the presence of the selective inhibitor of CathB CA-074-Me [33] or by overexpressing the enzymatically inactive mutant GFP-CathB-C29A. As shown in Fig. 3a-b , both the inhibitor CA-074-Me and the inactive mutant GFP-CathB-C29A prevented MILH-induced cell death (1.2 ± 0.1 and 1.5 ± 0.1-fold over basal value vs 2.5 ± 0.1-fold). In contrast, overexpression of wildtype CathB (GFP-CathB-WT) augmented the efficiency of MILH to eradicate cancer cells (4.1 ± 0.2 vs 3.0 ± 0.3-fold over basal, Fig. 3c ) reaching 34.8% of dead cells comparatively to 17.3% of dead cells in the absence of CathB-WT overexpression. These results indicate that cell death induced by MILH is dependent on CathB activity.
MILH induces cell death through a Caspase-1-dependent but Caspase-3 independent mechanism
So far, in most circumstances, partial LMP induce cell death through an apoptotic pathway, by triggering a cascade of regulated molecular events leading to activation of the effector apoptotic enzyme Caspase-3 [3, 14] . We therefore investigated whether MILH also induces cell death through an apoptotic pathway. Surprisingly, the Caspase-3 inhibitor did not inhibit MILH-induced cell death (2.7 ± 0.2% vs 2.8 ± 0.2-fold over basal) whereas it prevented cell death induced by staurosporine used as a reference agent to stimulate apoptosis (Fig. 4a) . Moreover, Caspase-3 activation was not detected neither by confocal microscopy using a fluorescent substrate (Fig. 4b) , nor by western blot as shown by the absence of Pro-Caspase-3 cleavage (Fig. S8) . We also showed that MILH did not modify mitochondrial outer membrane permeabilization (MOMP), which critically relies on apoptotic cell death, as demonstrated with staurosporine treatment (Fig. 4c, S9) , 4 h or 24 h after AMF exposure [34] . Hence, cell death induced by MILH does not involve an apoptotic pathway.
In some non-epithelial cells, especially in macrophages exposed to infectious agents, the release of lysosomal hydrolases such as CathB induced after LMP was shown to activate a non-apoptotic cell death pathway involving Caspase-1 activation [35] . We therefore verified Caspase-1 expression in INR1G9-CCK2R cells (Fig. S10) and determined whether Caspase-1 was involved in MILH-induced tumor cell death.
Incubation of INR1G9-CCK2R cells with Caspase-1 inhibitor prevented cell death induced by MILH (1.6 ± 0.2-vs 2.8 ± 0.2-fold over basal, Fig. 4d) . Likewise, overexpression of Caspase-1-C284A inactive mutant inhibited cell death (1.5 ± 0.2 vs 3.0 ± 0.2-fold over basal, Fig. 4e) . It was also noticed that overexpression of Caspase-1-C284A inactive mutant lowered basal rate of cell death (amount of dead cells: 1.2 ± 0.4% vs 6.5 ± 0.9%). Moreover, MILH increased Caspase-1 activation (3.5 ± 0.4, 9.0 ± 1.3 and 12.5 ± 2.4-fold over basal 1 h, 4 h and 18 h after AMF exposure) and this activation was inhibited by CathB inhibitor CA-074-Me (Fig. 4f, S11 ). It is also important to note that 84.5 ± 2.3% of cells presenting an upregulated Caspase-1 activity were labeled with AnnexinV (Fig. 4g) . Taken together, these results demonstrate that cell death induced by MILH does not involve an apoptotic pathway, but requires Caspase-1 and Cath-B activities.
An important function of Caspase-1 consists to process the precursor of the inflammatory cytokines, interleukine-1β (Il1β) and interleukine-18 (Il-18) into their active forms [36] . Furthermore, activation of Caspase-1 in cells is a hallmark of pyroptosis, which is a form of regulated cell death, usually defined by several additional biochemical features such as independence of apoptotic caspases, Ann/PI positive labeling, DNA fragmentation [37] . The current study demonstrates that MILH-induced cell death is dependent on Caspase-1 activation and featured by Ann/PI labeling. Owing to functions of Caspase-1 in immune cells, we first investigated whether MILH-induced Caspase-1 activation was associated with Il1β secretion (Fig. 5a) . Our results show that, in INR1G9-CCK2R cells which were LPS-primed or not, MILH did not increase Il1β secretion relative to control cells. In contrast, in LPSprimed Thp1 macrophages, which were used as reference cells for Il1β processing and secretion, levels of Il1β secretion were increased by 27.7 ± 3.2-fold over basal value. The levels of Il1β secretion by INR1G9-CCK2R cells were very low (< 2 pg/mg of cell proteins) as was that of Pro-Il1β expression, comparatively to macrophages cells (Fig. 5b) . Hence, MILH induces Caspase-1-dependent cell death without activating the Caspase-1 pro-inflammatory response in the endocrine tumoral INR1G9-CCK2R cells. However, we could not exclude that proinflammatory response could be activated by MILH in cancer cells expressing higher level of Pro-Il1β.
Then, we characterized DNA fragmentation caused by MILH using TUNEL assay which consists in the incorporation of fluorescent dUTP (deoxyuridine triphosphate) into free 3′-hydroxyl termini generated by genomic DNA fragmentation (Fig. 5c) . Results indicate that, after 6 h of AMF exposure, DNA fragmentation increased by 3.4 ± 0.5-fold relative to control cells (22.9 ± 3.8% vs 8.5 ± 1.4% of positive cells). Of note, DNA fragmentation induced by MILH was less abundant than that caused by staurosporine or by 42°C water bath (40.1 ± 4.9% or 52.6 ± 14.0% of positive cells, respectively). Secondly, we characterized the type of DNA fragmentation caused by MILH (Fig. 5d) . In contrast to staurosporine treatment which provoked regular inter-nucleosomic DNA fragmentation characterized by DNA ladder [37] , MILH did not induce the formation of the characteristic laddering pattern associated with apoptosis. In conclusion, our results show that MILH induced a non-apoptotic Caspase-1 dependent cell death related to pyroptosis which occurred without Il1β secretion and which was characterized by the formation of TUNEL-positive cells without exhibiting a laddering pattern [37, 38] . The preceding experiments analyzed the effects and mechanisms of MILH applied to the pancreatic endocrine tumor cells INR1G9-CCK2R. Herein, we extended the experiments to two other tumor cell lines, the gastric cell line AGS-CCK2R and the pancreatic cell line AR4-2J, which express the CCK2R at low levels (~100 fmol/10 6 cells) [39] . Cell survival data show that, 24 h after AMF exposure, MILH has eradicated 22.0 ± 4.5% of AGS-CCK2R cells and 23.1 ± 1.3% of AR4-2 J cells presenting Gastrin-MNPs mainly in their lysosomes (Fig. 6a, S12 ). In the same conditions, 56.6 ± 4.0% and 42.7 ± 6.4% of HEK-CCK2R . MILH triggers a non-apoptotic cell death mechanism related to pyroptosis. a-b) INR1G9-CCK2R cells were treated or not with 500 ng/ml of LPS, Gastrin-MNPs and exposed or not to AMF. As a positive control, Thp1 macrophages were treated with 500 ng/ml LPS. Il1-β release in culture supernatant was assayed with an ELISA kit (a). Pro-Il1β expression was analyzed by Western blot of total cell lyzates (b). Representative immunoblot of 3 separate experiments. c-d) INR1G9-CCK2R cells having or not internalized Gastrin-MNPs were exposed or not to AMF. As controls of apoptotis and necrosis, cells were respectively treated with 1 μM of staurosporine (6 h) or incubated at 42°C in a water-bath (30-min). DNA fragmentation was detected by TUNEL assay, 6 h after AMF exposure. 2000-3000 cells/ experiments were counted by confocal microscopy analysis and expressed as % of total cells labeled with fluorescent dUTP (deoxyuridine triphosphate) which is incorporated into free 3′-hydroxyl termini generated by genomic DNA fragmentation (c). DNA fragmentation was detected using the DNA ladder approach (d). Results are the mean ± SEM of at least 5 separate experiments. Significant difference compared to the control condition corresponding to cells devoid of Gastrin-MNP in absence of AMF exposure was indicated above histogram bar. Statistical significances between other conditions are also indicated. cells were killed using 16 μg/ml or 1 μg Fe/ml of Gastrin-MNP respectively ( Fig. S13a-b) . Ann/PI labeling confirmed that MILH-induced cell death was detectable 4 h post-AMF (Fig. 6b ) and dead cells were more often labeled with PI in AGS-CCK2R and AR4-2 J cells than in INR1G9-CCK2R cells. MILH also triggered cell death in the non-tumoral embryonic kidney cell overexpressing the CCK2R (HEK-CCK2R: 2.0 ± 0.2 pmol/10 6 cells) previously used to characterize uptake and cellular trafficking of Gastrin-MNPs (Fig. S13c) [4, 40] . Determination of the uptake of Gastrin-MNPs by the different cells indicates that receptor-mediated uptake of MNPs by AGS-CCK2R, AR4-2J and INR1G9-CCK2R cells was 0.83 ± 0.23, 0.60 ± 0.13 and 3.38 ± 0.74 pg of Fe/cell which corresponded to 0.52 ± 0.22, 0.14 ± 0.02 and 1.07 ± 0.28 pg of magnetic Fe/cell, respectively, as measured by pEPR, after 24 h of intracellular accumulation (Fig. 6c) . Of note, in HEK-CCK2R cells, Gastrin-MNPs uptake was evaluated to be 4.01 ± 0.40 and 1.48 ± 0.22 pg of total and magnetic Fe/cell, respectively (Fig. S13d) .
We finally assessed that the signaling pathway involved in MILHinduced cell death in AGS-CCK2R, AR4-2J and HEK-CCK2R cells was similar to that identified in INR1G9-CCK2R. Firstly, no significant Caspase-3 activation could be detected in the 3 cell lines, similarly to INR1G9-CCK2R cells (Fig. S13e, S14) . Secondly, MILH increased Caspase-1 activation, 4 h after AMF exposure, by 3.5 ± 0.1, 3.6 ± 0.2 and 6.2 ± 0.6-fold in AGS-CCK2R, AR4-2J and HEK-CCK2R respectively, similarly to INR1G9-CCK2R cells (Fig. 6d, S13f) .
These above results demonstrate that MILH is effective in inducing the death of cancer cells from three different types of cancer (pancreatic endocrine, pancreatic exocrine and gastric) even if the targeted receptor is expressed at low levels and if minute amounts of Gastrin-MNPs are internalized. Moreover, in the three cancers, as well as in HEK cells, MILH-induced cell death occurs through activation of Caspase-1 and without activation of Caspase-3, indicating that MILH triggers a nonapoptotic cell death pathway following lysosome damage which is dependent on Caspase-1 activation.
Discussion
Following the publication of the proof-of-concept of anti-cancer nanotherapy using ligand-grafted MNPs specifically internalized via cell surface receptor, this study gained insight into the mechanisms at the origin of cell death induced by MILH (Fig. 6e) . Using Gastrin-MNPs which specifically target lysosomes of tumoral cells expressing the CCK2R as a killing agent, we demonstrate that tumor cell death induced by MILH occurs through a Caspase-1-dependent mechanism, but not an apoptotic signaling pathway, since Caspase-3 was not activated. This mechanism of MILH-induced cell death was demonstrated in pancreatic endocrine tumor cells as well as in gastric and pancreatic exocrine tumor cells expressing the CCK2R.
MILH first upregulates the catalysis of ROS production through the Fenton-type reaction within lysosomes which subsequently causes lipid peroxidation, followed by LMP and the leakage of lysosomal content into the cytosol. Among the lysosomal enzymes, CathB plays a critical role in cell death and activates Caspase-1. Thus, MILH-induced tumor cell death can be related to pyroptosis mainly described in macrophages, but rarely in epithelial cells [35, 41, 42] . Indeed, we showed that dead cells present AnnV and/or PI positive labelings and irregular DNA fragmentation (TUNEL positive staining without laddering pattern) as previously observed in pyroptotic macrophages [37, 38, 43] . However, whilst Caspase-1-dependent cell death by pyroptosis in macrophages is usually associated with pro-inflammatory responses resulting from Caspase-1 cleavage of Il-1β and -18, MILH did not increase Il-1β cleavage. These last results are in line with recent studies showing that Caspase-1 can induce pyroptotic cell death independently of Il1-β processing [44] [45] [46] . On the other hand, Pro-Il1β is expressed at low levels in our tumor cell model. Thus, we cannot not exclude that proinflammatory response would be activated by MILH in cancer cells expressing higher level of Pro-IL-1β.
Our current knowledge about Caspase-1 indicates that Caspase-1 is synthesized as a cytosolic, inactive, monomeric zymogen (pro-Caspase-1) that is thought to be activated by dimerization and autoproteolytic processing, resulting in generation of large and small subunits (called p20 and p10) of the catalytically active enzyme [47, 48] . This activation step is preceded by recruitment of Pro-Caspase-1 into inflammasomes, which are multiprotein signaling complexes. Furthermore, a direct processing of Caspase-1 by CathB [49, 50] or an indirect mechanism of activation through CathB-induced activation of inflammasome complexes [41, [50] [51] [52] were reported. In the current study of MILH-induced cell death, CathB activation is critical for Caspase-1 activation and tumor cell death indicating that one of these two mechanisms may function, but this remains to be determined more precisely.
Conclusion
The present study provides essential new data on the mechanism whereby targeted MNPs induce the death of tumor cells when exposed to a high frequency magnetic field. The central role of the Fenton reaction that produces ROS within lysosomes, together with that of CathB and Caspase-1, represent the key elements which are the basis for the optimization of Magnetic Intra-Lysosomal Hyperthermia or MILH strategies to kill cancer cells and their future developments as an antitumoral option.
Supplementary data to this article can be found online at https:// doi.org/10.1016/j.jconrel.2017.11.050.
